nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCB1—peripheral nervous system neoplasm	0.285	1	CbGaD
Pantoprazole—ABCG2—Topotecan—peripheral nervous system neoplasm	0.073	0.149	CbGbCtD
Pantoprazole—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0506	0.103	CbGbCtD
Pantoprazole—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0311	0.0634	CbGbCtD
Pantoprazole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0301	0.0613	CbGbCtD
Pantoprazole—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0291	0.0592	CbGbCtD
Pantoprazole—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0285	0.0581	CbGbCtD
Pantoprazole—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0263	0.0536	CbGbCtD
Pantoprazole—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0263	0.0536	CbGbCtD
Pantoprazole—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0252	0.0513	CbGbCtD
Pantoprazole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0241	0.049	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0195	0.0396	CbGbCtD
Pantoprazole—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0182	0.0371	CbGbCtD
Pantoprazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0158	0.0321	CbGbCtD
Pantoprazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0147	0.0298	CbGbCtD
Pantoprazole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0118	0.024	CbGbCtD
Pantoprazole—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0112	0.0229	CbGbCtD
Pantoprazole—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0108	0.022	CbGbCtD
Pantoprazole—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0105	0.0213	CbGbCtD
Pantoprazole—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0103	0.021	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00702	0.0143	CbGbCtD
Pantoprazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00673	0.0137	CbGbCtD
Pantoprazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00617	0.0126	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00421	0.00856	CbGbCtD
Pantoprazole—Omeprazole—ABCB1—peripheral nervous system neoplasm	0.00043	0.522	CrCbGaD
Pantoprazole—Lansoprazole—ABCB1—peripheral nervous system neoplasm	0.000393	0.478	CrCbGaD
Pantoprazole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000291	CcSEcCtD
Pantoprazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	6.49e-05	0.000291	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000289	CcSEcCtD
Pantoprazole—Rash—Dactinomycin—peripheral nervous system neoplasm	6.45e-05	0.000289	CcSEcCtD
Pantoprazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	6.43e-05	0.000288	CcSEcCtD
Pantoprazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000287	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	6.39e-05	0.000286	CcSEcCtD
Pantoprazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	6.38e-05	0.000286	CcSEcCtD
Pantoprazole—Fatigue—Etoposide—peripheral nervous system neoplasm	6.38e-05	0.000286	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000286	CcSEcCtD
Pantoprazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000284	CcSEcCtD
Pantoprazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000284	CcSEcCtD
Pantoprazole—Pain—Etoposide—peripheral nervous system neoplasm	6.33e-05	0.000284	CcSEcCtD
Pantoprazole—Constipation—Etoposide—peripheral nervous system neoplasm	6.33e-05	0.000284	CcSEcCtD
Pantoprazole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000283	CcSEcCtD
Pantoprazole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000283	CcSEcCtD
Pantoprazole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000283	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000281	CcSEcCtD
Pantoprazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.27e-05	0.000281	CcSEcCtD
Pantoprazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.25e-05	0.00028	CcSEcCtD
Pantoprazole—Sweating—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000279	CcSEcCtD
Pantoprazole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000279	CcSEcCtD
Pantoprazole—Haematuria—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000278	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000276	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000276	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000275	CcSEcCtD
Pantoprazole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000275	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000274	CcSEcCtD
Pantoprazole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.000274	CcSEcCtD
Pantoprazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.1e-05	0.000273	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000273	CcSEcCtD
Pantoprazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.07e-05	0.000272	CcSEcCtD
Pantoprazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.000272	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.000271	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	6.05e-05	0.000271	CcSEcCtD
Pantoprazole—Dizziness—Vincristine—peripheral nervous system neoplasm	6.04e-05	0.000271	CcSEcCtD
Pantoprazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.03e-05	0.00027	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.00027	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.00027	CcSEcCtD
Pantoprazole—Rash—Alitretinoin—peripheral nervous system neoplasm	5.98e-05	0.000268	CcSEcCtD
Pantoprazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.97e-05	0.000268	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000267	CcSEcCtD
Pantoprazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.95e-05	0.000267	CcSEcCtD
Pantoprazole—Headache—Alitretinoin—peripheral nervous system neoplasm	5.94e-05	0.000266	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000264	CcSEcCtD
Pantoprazole—Urticaria—Etoposide—peripheral nervous system neoplasm	5.88e-05	0.000264	CcSEcCtD
Pantoprazole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000263	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000263	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000263	CcSEcCtD
Pantoprazole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000262	CcSEcCtD
Pantoprazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.85e-05	0.000262	CcSEcCtD
Pantoprazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.85e-05	0.000262	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000262	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000262	CcSEcCtD
Pantoprazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000262	CcSEcCtD
Pantoprazole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000262	CcSEcCtD
Pantoprazole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.00026	CcSEcCtD
Pantoprazole—Vomiting—Vincristine—peripheral nervous system neoplasm	5.81e-05	0.00026	CcSEcCtD
Pantoprazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.79e-05	0.00026	CcSEcCtD
Pantoprazole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.00026	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000259	CcSEcCtD
Pantoprazole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000258	CcSEcCtD
Pantoprazole—Rash—Vincristine—peripheral nervous system neoplasm	5.76e-05	0.000258	CcSEcCtD
Pantoprazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.75e-05	0.000258	CcSEcCtD
Pantoprazole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000258	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000257	CcSEcCtD
Pantoprazole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000257	CcSEcCtD
Pantoprazole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000257	CcSEcCtD
Pantoprazole—Headache—Vincristine—peripheral nervous system neoplasm	5.72e-05	0.000257	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000255	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000254	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000253	CcSEcCtD
Pantoprazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.63e-05	0.000252	CcSEcCtD
Pantoprazole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000252	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000252	CcSEcCtD
Pantoprazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.53e-05	0.000248	CcSEcCtD
Pantoprazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000247	CcSEcCtD
Pantoprazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000245	CcSEcCtD
Pantoprazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.45e-05	0.000244	CcSEcCtD
Pantoprazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000244	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000243	CcSEcCtD
Pantoprazole—Nausea—Vincristine—peripheral nervous system neoplasm	5.43e-05	0.000243	CcSEcCtD
Pantoprazole—Flushing—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000243	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000243	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000242	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000242	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000241	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.00024	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000239	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000239	CcSEcCtD
Pantoprazole—Asthenia—Etoposide—peripheral nervous system neoplasm	5.31e-05	0.000238	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000238	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000237	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.000236	CcSEcCtD
Pantoprazole—Chills—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000235	CcSEcCtD
Pantoprazole—Pruritus—Etoposide—peripheral nervous system neoplasm	5.23e-05	0.000235	CcSEcCtD
Pantoprazole—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000234	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000233	CcSEcCtD
Pantoprazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000231	CcSEcCtD
Pantoprazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.14e-05	0.00023	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000229	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000229	CcSEcCtD
Pantoprazole—Rash—Cisplatin—peripheral nervous system neoplasm	5.09e-05	0.000228	CcSEcCtD
Pantoprazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.09e-05	0.000228	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000228	CcSEcCtD
Pantoprazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.06e-05	0.000227	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000226	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000226	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000225	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000224	CcSEcCtD
Pantoprazole—Tension—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000224	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000223	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000221	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.00022	CcSEcCtD
Pantoprazole—Dizziness—Etoposide—peripheral nervous system neoplasm	4.89e-05	0.000219	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000219	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000219	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000217	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000216	CcSEcCtD
Pantoprazole—Nausea—Cisplatin—peripheral nervous system neoplasm	4.8e-05	0.000215	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000215	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000214	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000212	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000211	CcSEcCtD
Pantoprazole—Vomiting—Etoposide—peripheral nervous system neoplasm	4.7e-05	0.000211	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000211	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000211	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000209	CcSEcCtD
Pantoprazole—Rash—Etoposide—peripheral nervous system neoplasm	4.67e-05	0.000209	CcSEcCtD
Pantoprazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.66e-05	0.000209	CcSEcCtD
Pantoprazole—Headache—Etoposide—peripheral nervous system neoplasm	4.64e-05	0.000208	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000208	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000207	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000206	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000205	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000205	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.000205	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000204	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000204	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000204	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000203	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000201	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.0002	CcSEcCtD
Pantoprazole—Cough—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000199	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000199	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000197	CcSEcCtD
Pantoprazole—Nausea—Etoposide—peripheral nervous system neoplasm	4.39e-05	0.000197	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000197	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000196	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000195	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000194	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000194	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000194	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000194	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000193	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000193	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.000192	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.00019	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.00019	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000189	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000189	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000189	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000187	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000186	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000186	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000186	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000185	CcSEcCtD
Pantoprazole—Infection—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000185	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000184	CcSEcCtD
Pantoprazole—Shock—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000183	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000183	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.000182	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000182	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000182	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000181	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000181	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.00018	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000179	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000179	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000179	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000179	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000178	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000177	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000177	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000176	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000174	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000173	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000172	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000172	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000171	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000169	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000169	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000169	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000168	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000168	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000168	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000167	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000167	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000166	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000166	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000165	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000164	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000164	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000162	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000161	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000161	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.00016	CcSEcCtD
Pantoprazole—Pain—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000159	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000159	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000157	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000156	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000154	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000153	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000153	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000153	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000152	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000151	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.00015	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000149	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000148	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000148	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000147	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000147	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000147	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000147	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000142	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000141	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000137	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000137	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000136	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000136	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000133	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000132	CcSEcCtD
Pantoprazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000127	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000127	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000123	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.74e-05	0.000123	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000122	CcSEcCtD
Pantoprazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000118	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000118	CcSEcCtD
Pantoprazole—Rash—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000117	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.61e-05	0.000117	CcSEcCtD
Pantoprazole—Headache—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000116	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000114	CcSEcCtD
Pantoprazole—Nausea—Epirubicin—peripheral nervous system neoplasm	2.46e-05	0.00011	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000109	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000108	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000108	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000108	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.28e-05	0.000102	CcSEcCtD
